Concert Pharmaceuticals is a biopharmaceutical company focused on developing small molecule drugs for a variety of medical conditions, including central nervous system disorders, genetic diseases, and inflammatory disease. The company's clinical-stage product candidates include AVP-786, CTP-499, and CTP-354, which are currently in various stages of clinical trials. AVP-786 is being studied as a treatment for neurologic and psychiatric disorders, while CTP-499 is being tested for chronic kidney disease in type 2 diabetes patients. CTP-354 is in its early stages of clinical trials for spasticity associated with spinal cord injury and multiple sclerosis.
Concert Pharmaceuticals Inc's ticker is CNCE
The company's shares trade on the NASDAQ stock exchange
They are based in Lexington, Massachusetts
There are 51-200 employees working at Concert Pharmaceuticals Inc
It is http://www.concertpharma.com/
Concert Pharmaceuticals Inc is in the Healthcare sector
Concert Pharmaceuticals Inc is in the Biotechnology industry
The following five companies are Concert Pharmaceuticals Inc's industry peers: